Assignee
RIGEL PHARMACEUTICALS INC
US·390 granted patents·99 pending applications·6,025 citations·filing 1997–2025
Top patents by PatentIndex Score
489 records- 0199US8853397B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Oct 7, 2014·45 cites·7 claims
- 0299US8822685B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Sep 2, 2014·43 cites·17 claims
- 0399US7820819B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Oct 26, 2010·87 cites·17 claims
- 0499US7655797B2Intermediates for making 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Feb 2, 2010·81 cites·21 claims
- 0599US7642351B22,4-Pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jan 5, 2010·105 cites·14 claims
- 0699US7589200B25-Fluoro-4N-phenyl-4-pyrimidineamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Sep 15, 2009·102 cites·18 claims
- 0799US7582648B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·114 cites·3 claims
- 0899US7557210B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Jul 7, 2009·190 cites·16 claims
- 0999US7550460B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Jun 23, 2009·95 cites·18 claims
- 1099US7498435B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 3, 2009·93 cites·21 claims
- 1199US7485724B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 3, 2009·119 cites·20 claims
- 1299US7452879B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 18, 2008·110 cites·13 claims
- 1399US7449458B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 11, 2008·108 cites·13 claims
- 1499US7435814B22,4-Pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Oct 14, 2008·94 cites·11 claims
- 1599US7332484B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 19, 2008·146 cites·4 claims
- 1699US7329672B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 12, 2008·130 cites·19 claims
- 1799US7329671B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 12, 2008·147 cites·19 claims
- 1899US7122542B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Oct 17, 2006·218 cites·6 claims
- 1999US7060827B2Intermediates useful for making 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Jun 13, 2006·255 cites·11 claims
- 2098US11479543B2Heterocyclic RIP1 kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Oct 25, 2022·5 cites·3 claims
- 2198US8748597B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jun 10, 2014·30 cites·1 claims
- 2298US7906644B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 15, 2011·46 cites·1 claims
- 2398US7825116B2N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediaminesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 2, 2010·55 cites·8 claims
- 2498US7812029B1Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Oct 12, 2010·73 cites·23 claims
- 2598US7563892B1Prodrugs of 2,4 pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jul 21, 2009·52 cites·8 claims
- 2698US7560466B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jul 14, 2009·56 cites·11 claims
- 2798US7517886B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Apr 14, 2009·141 cites·28 claims
- 2898US7491732B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 17, 2009·105 cites·6 claims
- 2997US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 3097US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 3197US10941134B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·18 cites·20 claims
- 3297US10377742B2AMPK-activating heterocyclic compounds and methods for using the sameRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Aug 13, 2019·20 cites·21 claims
- 3397US7989448B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Aug 2, 2011·35 cites·20 claims
- 3497US7884111B22,4-pyrimidinediamine compounds and uses as anti-proliferative agentsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 8, 2011·75 cites·12 claims
- 3597US7858633B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·66 cites·5 claims
- 3697US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 3797US7803939B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Sep 28, 2010·77 cites·21 claims
- 3897US7538108B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted May 26, 2009·43 cites·19 claims
- 3997US7528242B2Methods and compositions comprising Renilla GFPRIGEL PHARMACEUTICALS INC·Filed 2005·Granted May 5, 2009·71 cites·3 claims
- 4097US6667152B2Method for selective inactivation of viral replicationRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Dec 23, 2003·73 cites·20 claims
- 4196US11584758B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·5 cites·37 claims
- 4296US11332451B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted May 17, 2022·3 cites·13 claims
- 4396US10815206B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·16 cites·17 claims
- 4496US10590121B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·10 cites·37 claims
- 4596US10259826B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Apr 16, 2019·6 cites·7 claims
- 4696US9913842B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·8 cites·28 claims
- 4796US7947698B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·55 cites·54 claims
- 4896US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 4996US7754714B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·39 cites·24 claims
- 5096US7709482B2Polycyclic heteroaryl substituted triazoles useful as Axl inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·34 cites·62 claims
Showing the top 50 of 489 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when RIGEL PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →